Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Connective tissue growth factor and cardiac diastolic dysfunction: human data from the Taiwan diastolic heart failure registry and molecular basis by cellular and animal models.

Wu CK, Wang YC, Lee JK, Chang SN, Su MY, Yeh HM, Su MJ, Chen JJ, Chiang FT, Hwang JJ, Lin JL, Tsai CT.

Eur J Heart Fail. 2014 Feb;16(2):163-72. doi: 10.1002/ejhf.33. Epub 2013 Dec 11.

2.

Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices.

Wu CK, Su MY, Lee JK, Chiang FT, Hwang JJ, Lin JL, Chen JJ, Liu FT, Tsai CT.

Sci Rep. 2015 Nov 19;5:17007. doi: 10.1038/srep17007.

3.

Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes.

Brooks BA, Franjic B, Ban CR, Swaraj K, Yue DK, Celermajer DS, Twigg SM.

Diabetes Obes Metab. 2008 Sep;10(9):739-46. Epub 2007 Oct 15.

PMID:
17941867
4.

Rad GTPase inhibits cardiac fibrosis through connective tissue growth factor.

Zhang J, Chang L, Chen C, Zhang M, Luo Y, Hamblin M, Villacorta L, Xiong JW, Chen YE, Zhang J, Zhu X.

Cardiovasc Res. 2011 Jul 1;91(1):90-8. doi: 10.1093/cvr/cvr068. Epub 2011 Mar 7.

5.

Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis.

Koitabashi N, Arai M, Kogure S, Niwano K, Watanabe A, Aoki Y, Maeno T, Nishida T, Kubota S, Takigawa M, Kurabayashi M.

Hypertension. 2007 May;49(5):1120-7. Epub 2007 Mar 19.

6.

Myocardial connective tissue growth factor (CCN2/CTGF) attenuates left ventricular remodeling after myocardial infarction.

Gravning J, Ørn S, Kaasbøll OJ, Martinov VN, Manhenke C, Dickstein K, Edvardsen T, Attramadal H, Ahmed MS.

PLoS One. 2012;7(12):e52120. doi: 10.1371/journal.pone.0052120. Epub 2012 Dec 20.

7.
8.

Connective tissue growth factor regulates cardiac function and tissue remodeling in a mouse model of dilated cardiomyopathy.

Koshman YE, Sternlicht MD, Kim T, O'Hara CP, Koczor CA, Lewis W, Seeley TW, Lipson KE, Samarel AM.

J Mol Cell Cardiol. 2015 Dec;89(Pt B):214-22. doi: 10.1016/j.yjmcc.2015.11.003. Epub 2015 Nov 5.

9.

miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling.

Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, Herias V, van Leeuwen RE, Schellings MW, Barenbrug P, Maessen JG, Heymans S, Pinto YM, Creemers EE.

Circ Res. 2009 Jan 30;104(2):170-8, 6p following 178. doi: 10.1161/CIRCRESAHA.108.182535. Epub 2008 Dec 18.

10.

Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction.

Kasner M, Westermann D, Lopez B, Gaub R, Escher F, Kühl U, Schultheiss HP, Tschöpe C.

J Am Coll Cardiol. 2011 Feb 22;57(8):977-85. doi: 10.1016/j.jacc.2010.10.024.

11.

Diastolic dysfunction and atrial fibrillation.

Nagarakanti R, Ezekowitz M.

J Interv Card Electrophysiol. 2008 Aug;22(2):111-8. doi: 10.1007/s10840-008-9203-8. Epub 2008 Feb 9. Review.

PMID:
18264747
12.

Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.

Szabó Z, Magga J, Alakoski T, Ulvila J, Piuhola J, Vainio L, Kivirikko KI, Vuolteenaho O, Ruskoaho H, Lipson KE, Signore P, Kerkelä R.

Hypertension. 2014 Jun;63(6):1235-40. doi: 10.1161/HYPERTENSIONAHA.114.03279. Epub 2014 Mar 31.

13.

CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload.

Gravning J, Ahmed MS, von Lueder TG, Edvardsen T, Attramadal H.

Int J Cardiol. 2013 Oct 3;168(3):2049-56. doi: 10.1016/j.ijcard.2013.01.165. Epub 2013 Feb 26.

PMID:
23452880
14.

[Expression of connective tissue growth factor in cardiomyocyte of young rats with heart failure and benazepril intervention].

Zhang Q, Yi QJ, Qian YR, Li R, Deng B, Wang Q.

Zhonghua Er Ke Za Zhi. 2006 Oct;44(10):733-7. Chinese.

PMID:
17229371
15.

Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan.

Iwamoto M, Hirohata S, Ogawa H, Ohtsuki T, Shinohata R, Miyoshi T, Hatipoglu FO, Kusachi S, Yamamoto K, Ninomiya Y.

Hypertens Res. 2010 Dec;33(12):1305-11. doi: 10.1038/hr.2010.189. Epub 2010 Oct 14.

PMID:
20944640
16.

CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis.

Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH.

J Mol Cell Cardiol. 2000 Oct;32(10):1805-19.

PMID:
11013125
17.

Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.

Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ.

J Am Coll Cardiol. 2008 Nov 4;52(19):1574-80. doi: 10.1016/j.jacc.2008.06.049.

18.

Induction of myocardial connective tissue growth factor in pacing-induced heart failure in pigs.

Ahmed MS, von Lueder TG, Øie E, Kjekshus H, Attramadal H.

Acta Physiol Scand. 2005 May;184(1):27-36.

PMID:
15847641
19.

Locally expressed IGF1 propeptide improves mouse heart function in induced dilated cardiomyopathy by blocking myocardial fibrosis and SRF-dependent CTGF induction.

Touvron M, Escoubet B, Mericskay M, Angelini A, Lamotte L, Santini MP, Rosenthal N, Daegelen D, Tuil D, Decaux JF.

Dis Model Mech. 2012 Jul;5(4):481-91. doi: 10.1242/dmm.009456. Epub 2012 Apr 5.

20.

Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload.

Panek AN, Posch MG, Alenina N, Ghadge SK, Erdmann B, Popova E, Perrot A, Geier C, Dietz R, Morano I, Bader M, Ozcelik C.

PLoS One. 2009 Aug 25;4(8):e6743. doi: 10.1371/journal.pone.0006743. Erratum in: PLoS One. 2009;4(9). doi: 10.1371/annotation/818d7cc6-3ec0-4fc5-82e1-8e9b6ceca336. Morano, Rainer Dietz Ingo [corrected to Dietz, Rainer]; Morano, Ingo [added].

Supplemental Content

Support Center